Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02566551

Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment.

Prospective Controlled Randomized Study of Prostatic Arteries Embolization (PAE) vs Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia (BPH) Treatment.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Group of Research in Minimally Invasive Techniques · Academic / Other
Sex
Male
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective randomized controlled study is to compare the improvement of symptoms from benign prostatic hyperplasia (BPH) and the improvement of QoL, in patients undergoing prostatic artery embolization (PAE) or conventional transurethral resection of the prostate (TURP).

Detailed description

The purpose of this prospective randomized controlled study is to compare the improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) and the improvement of QoL assessed by QoL questionnaire in patients undergoing prostatic artery embolization (PAE) to patients of similar characteristics undergoing conventional transurethral resection of the prostate (TURP).

Conditions

Interventions

TypeNameDescription
PROCEDUREPAEEmbolization of the prostate with gelatin embolization spheres via microcatheterization of the prostatic arteries.
DEVICEGelatin microspheresGelatin embolization microspheres (300-500 microns) will be used as embolic material for the prostatic artery embolization (PAE) protocol
PROCEDURETURPBipolar transurethral resection of the prostate
DEVICEBipolar electrosurgery generatorA bipolar electrosurgery generator will be used to perform transurethral resection of the prostate (TURP)

Timeline

Start date
2015-10-01
Primary completion
2018-05-01
Completion
2019-05-01
First posted
2015-10-02
Last updated
2019-07-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02566551. Inclusion in this directory is not an endorsement.